Prothena
Price & Volume
Stats
See more52W Range | $4.32-$11.80 |
Market Cap | $510.9M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $57.9M |
Revenue Growth (YoY) | 1,706.4% |
Gross Profit (12 Mos) | -$38.7M |
Diluted EPS | -$2.81 |
News
See moreYahoo Finance • 10 days ago
Prothena Reports First Quarter 2026 Financial Results and Business Highlights
Yahoo Finance • 20 days ago
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
Yahoo Finance • 2 months ago
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
Yahoo Finance • 3 months ago
Prothena authorizes up to $100 million share repurchase plan
About
CEO | Dr. Gene G. Kinney Ph.D. |
Address | 77 Sir John Rogerson?s Quay, Dublin, Ireland, D02 VK60 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 67 |